Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 102   

Articles published

SHP 4,260.00 -29.00 (-0.68%)
price chart
Will AstraZeneca plc, Shire plc and Smith & Nephew plc help you survive Brexit?
Meanwhile, Shire (LSE: SGP) has a rather less certain future than many of its pharmaceutical peers. That's because it recently agreed to a $32bn acquisition of Baxalta and while this positions the company for long-term profits growth, there are ...
Shire PLC 30.2% Potential Upside Indicated by Deutsche Bank
Shire PLC with EPIC/TICKER LON:SHP had its stock rating noted as 'Resumes' with the recommendation being set at 'BUY' today by analysts at Deutsche Bank.
Shire PLC (SHP) Rating Reiterated by Deutsche Bank  Let Me Know About This
Deutsche Bank Indicates Potential 30.57% Increase In Shares Of Shire PLC  Risers & Fallers
Why Should Traders Buy Shire PLC (ADR) (NASDAQ:SHPG)?
Shire PLC (ADR) (NASDAQ:SHPG) has grabbed the attention from analysts, when it saw a value decrease of -1.73 percent in the last trading session.
Bryan Garnier Initiates Coverage on Shire PLC (ADR) to Buy  Trade Calls
Reliable stocks in today's share market: Shire plc (NASDAQ:SHPG)  The News Journal
Summary of Analysts Rating: Shire plc (NASDAQ:SHPG) , ARIAD Pharmaceuticals ...
Shire plc (LSE: SHP, NASDAQ: SHPG) reported that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the extension of the authorization of Revestive[�*] ...
Are City analysts wrong about Tesco plc, Shire plc & ARM Holdings plc?
Managing expectations will be very important for shares in Tesco (LSE: TSCO), Shire (LSE: SHP) and ARM Holdings (LSE: ARM) over the coming months.
Why AstraZeneca plc and Shire plc are 2 growth stars
30 years ago cancer was a disease that was almost incurable. Today, more people survive cancer than die from it. The world - particularly science and technology - continues to make real progress, day after day, and year after year.
A Deep Dive Into Shire's Business
This analysis will be split in two articles: one will be about Shire as a standalone company and the other will be about the combined entity because I really think that the deal will close.
You could beat the market with GlaxoSmithKline plc and Shire plc
GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) are two such companies. Shire is a world-leading producer of rare disease treatments, and the company is unlikely to be displaced from this position anytime soon.
Shire PLC (ADR) 19.4% Potential Upside Now Implied by Stifel
Shire PLC (ADR) with TICKER NASDAQ:SHPG has had its stock rating noted as 'Initiated' with the recommendation being set at 'BUY' yesterday by analysts at Stifel.
JP Morgan Maintains Shire PLC (ADR) to Overweight with Price Target $239.00  Trade Calls
Is Shire PLC (ADR) (NASDAQ:SHPG) an Incredibly Valuable Stock?  Street Report
Shire PLC 27.4% Potential Upside Indicated by HSBC
Shire PLC using EPIC/TICKER code LON:SHP has had its stock rating noted as 'Retains' with the recommendation being set at 'BUY' today by analysts at HSBC.
Weekly Investment Analysts' Ratings Changes for Shire PLC (SHP)  Web Breaking News
Shire PLC (LON:SHP) Issued With 'Overweight' Rating From JP Morgan ...  Share Trading News